NR Protein | Protein Name | Ligand ID | Ligand Name | EC 50 |
NR1H3 | Oxysterols receptor LXR-alpha | 10592 | (6-acetyloxy-1,4a-dimethyl-2,3,4,9,10,10a-hexahydrophenanthrene-1-carbonyl)6-acetyloxy-1,4a-dimethyl-2,3,4,9,10,10a-hexahydrophenanthrene-1-carboxylate | 0.002 |
NR1H3 | Oxysterols receptor LXR-alpha | 10589 | (6-acetyloxy-1,4a-dimethyl-2,3,4,9,10,10a-hexahydrophenanthrene-1-carbonyl)6-acetyloxy-1,4a-dimethyl-2,3,4,9,10,10a-hexahydrophenanthrene-1-carboxylate | 0.002 |
NR1H3 | Oxysterols receptor LXR-alpha | 10267 | N-[(2-chloro-6-fluorophenyl)methyl]-N-{[4-(3-methanesulfonylphenyl)phenyl]methyl}benzenesulfonamide | 0.006 |
NR1H3 | Oxysterols receptor LXR-alpha | 10409 | N-[(2-chloro-4-fluorophenyl)methyl]-N-{[4-(3-methanesulfonylphenyl)phenyl]methyl}benzenesulfonamide | 0.01 |
NR1H3 | Oxysterols receptor LXR-alpha | 10420 | N-[(2-chloro-6-fluorophenyl)methyl]-N-{[4-(3-methanesulfonylphenyl)phenyl]methyl}-2-methylbenzene-1-sulfonamide | 0.013 |
NR1H3 | Oxysterols receptor LXR-alpha | 10465 | N-(2,2,2-trifluoroethyl)-N-[4–(2,2,2-trifluoro-1-hydroxy-1-trifluoromethylethyl)-phenyl]-benzenesulfonamide | 0.02 |
NR1H3 | Oxysterols receptor LXR-alpha | 10354 | 2-benzyl-3-[3-(3-methanesulfonylphenoxy)phenyl]-8-(trifluoromethyl)imidazo[1,2-a]pyridine | 0.02 |
NR1H3 | Oxysterols receptor LXR-alpha | 10358 | 3-({3-[3-(3-methanesulfonylphenoxy)phenyl]-8-(trifluoromethyl)imidazo[1,2-a]pyridin-2-yl}methyl)-1,3-thiazolidine | 0.032 |
NR1H3 | Oxysterols receptor LXR-alpha | 7890 | 6-hydroxy-1,4a-dimethyl-N-[(1-phenylcyclohexyl)methyl]-1,2,3,4,4a,9,10,10a-octahydrophenanthrene-1-carboxamide | 0.05 |
NR1H3 | Oxysterols receptor LXR-alpha | 7893 | 1-(1,4a-dimethyl-1,2,3,4,4a,9,10,10a-octahydrophenanthrene-1-carbonyl)-4-phenylpiperidine | 0.07 |
NR1H3 | Oxysterols receptor LXR-alpha | 10483 | 2-(4-fluoro-2-methoxyphenyl)-5-(4-fluorophenyl)-3-(2,4,6-trifluorobenzoyl)-2,3-dihydro-1,3,4-thiadiazole | 0.07 |
NR1H3 | Oxysterols receptor LXR-alpha | 10245 | N-[(2-chloro-6-fluorophenyl)methyl]-N-{[4-(3-methanesulfonylphenyl)phenyl]methyl}-2,4,6-trimethylbenzene-1-sulfonamide | 0.079 |
NR1H3 | Oxysterols receptor LXR-alpha | 10431 | N-[(2-chloro-6-fluorophenyl)methyl]-N-{[4-(3-methanesulfonylphenyl)phenyl]methyl}-1-methyl-1H-imidazole-4-sulfonamide | 0.079 |
NR1H3 | Oxysterols receptor LXR-alpha | 10461 | (3S,8S,9S,10R,13R,14S,17R)-17-[(2R,6R)-7-hydroxy-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol | 0.085 |
NR1H3 | Oxysterols receptor LXR-alpha | 10527 | methyl 1-[4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)phenyl]-2-phenylpiperidine-2-carboxylate (anilinohexafluoroisopropanol 38) | 0.09 |
NR1H3 | Oxysterols receptor LXR-alpha | 10289 | N-[(2-chloro-6-fluorophenyl)methyl]-N-{[4-(3-methanesulfonylphenyl)phenyl]methyl}cyclopropanesulfonamide | 0.1 |
NR1H3 | Oxysterols receptor LXR-alpha | 10466 | N-methyl-N-[4-(2,2,2-trifluoro-1-hydroxy-1-trifluoromethylethyl)-phenyl]-benzenesulfonamide | 0.1 |
NR1H3 | Oxysterols receptor LXR-alpha | 10500 | 2-[4-[benzyl(2,2,2-trifluoroethyl)amino]-3-chlorophenyl]-1,1,1,3,3,3-hexafluoropropan-2-ol (anilinohexafluoroisopropanol 7) | 0.1 |
NR1H3 | Oxysterols receptor LXR-alpha | 10514 | 2-[3-chloro-4-[ethyl-[[5-methyl-2-[3-(trifluoromethyl)phenyl]-1,3-oxazol-4-yl]methyl]amino]phenyl]-1,1,1,3,3,3-hexafluoropropan-2-ol (anilinohexafluoroisopropanol 21) | 0.1 |
NR1H3 | Oxysterols receptor LXR-alpha | 10522 | methyl 2-[N-ethyl-4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)anilino]-2-phenylpropanoate (anilinohexafluoroisopropanol 33) | 0.1 |
NR1H3 | Oxysterols receptor LXR-alpha | 10411 | 2-[4-({[3-(3-benzyl-8-chloroquinolin-4-yl)phenyl]amino}methyl)phenyl]acetic acid | 0.121 |
NR1H3 | Oxysterols receptor LXR-alpha | 10278 | N-[(2-chloro-4-fluorophenyl)methyl]-N-{[4-(3-methanesulfonylphenyl)phenyl]methyl}-2,4,6-trimethylbenzene-1-sulfonamide | 0.126 |
NR1H3 | Oxysterols receptor LXR-alpha | 7921 | N-[4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)phenyl]-N-(2,2,2-trifluoroethyl)benzenesulfonamide | 0.135 |
NR1H3 | Oxysterols receptor LXR-alpha | 7883 | N-[1-(adamantan-1-yl)ethyl]-6-hydroxy-1,4a-dimethyl-1,2,3,4,4a,9,10,10a-octahydrophenanthrene-1-carboxamide | 0.14 |
NR1H3 | Oxysterols receptor LXR-alpha | 7895 | 1-(1,4a-dimethyl-1,2,3,4,4a,9,10,10a-octahydrophenanthrene-1-carbonyl)-3-phenylpiperidine | 0.15 |
NR1H3 | Oxysterols receptor LXR-alpha | 7897 | N-(1,4a-dimethyl-1,2,3,4,4a,9,10,10a-octahydrophenanthrene-1-carbonyl)-1-phenylcyclohexane-1-carboxamide | 0.17 |
NR1H3 | Oxysterols receptor LXR-alpha | 10581 | 2-[2-chloro-4-[methyl-[3-[[7-propyl-3-(trifluoromethyl)-1,2-benzoxazol-6-yl]oxy]propyl]amino]phenyl]acetic acid | 0.17 |
NR1H3 | Oxysterols receptor LXR-alpha | 10482 | 5-(4-chlorophenyl)-2-(2-methoxyphenyl)-3-(2,4,6-trifluorobenzoyl)-2,3-dihydro-1,3,4-thiadiazole | 0.18 |
NR1H3 | Oxysterols receptor LXR-alpha | 10575 | 2-[2-oxo-1-[3-[[7-propyl-3-(trifluoromethyl)-1,2-benzoxazol-6-yl]oxy]propyl]-3H-indol-5-yl]acetic acid | 0.18 |
NR1H3 | Oxysterols receptor LXR-alpha | 10467 | 2-[3-[3-[[2-chloro-3-(trifluoromethyl)phenyl]methyl-(2,2-diphenylethyl)amino]propoxy]phenyl]acetic acid | 0.19 |
NR1H3 | Oxysterols receptor LXR-alpha | 10502 | 2-[4-[benzyl(ethyl)amino]-3-chlorophenyl]-1,1,1,3,3,3-hexafluoropropan-2-ol (anilinohexafluoroisopropanol 9) | 0.2 |
NR1H3 | Oxysterols receptor LXR-alpha | 10510 | 2-[4-[[2-(3-chlorophenyl)-5-methyl-1,3-oxazol-4-yl]methyl-ethylamino]phenyl]-1,1,1,3,3,3-hexafluoropropan-2-ol (anilinohexafluoroisopropanol 17) | 0.2 |
NR1H3 | Oxysterols receptor LXR-alpha | 10513 | 2-[4-[ethyl-[[5-methyl-2-[3-(trifluoromethyl)phenyl]-1,3-oxazol-4-yl]methyl]amino]phenyl]-1,1,1,3,3,3-hexafluoropropan-2-ol (anilinohexafluoroisopropanol 20) | 0.2 |
NR1H3 | Oxysterols receptor LXR-alpha | 10526 | methyl 1-[4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)phenyl]-2-phenylpyrrolidine-2-carboxylate (anilinohexafluoroisopropanol 37) | 0.2 |
NR1H3 | Oxysterols receptor LXR-alpha | 10357 | 1-({3-[3-(3-methanesulfonylphenoxy)phenyl]-8-(trifluoromethyl)imidazo[1,2-a]pyridin-2-yl}methyl)piperidine | 0.204 |
NR1H3 | Oxysterols receptor LXR-alpha | 7886 | N-(adamantan-1-yl)-6-hydroxy-1,4a-dimethyl-1,2,3,4,4a,9,10,10a-octahydrophenanthrene-1-carboxamide | 0.22 |
NR1H3 | Oxysterols receptor LXR-alpha | 10495 | 3-[4-(1-benzoylindol-2-yl)phenyl]propanenitrile (benzamide derivative 8) | 0.22 |
NR1H3 | Oxysterols receptor LXR-alpha | 7909 | 2-(4-{3-[3-benzyl-8-(trifluoromethyl)quinolin-4-yl]phenoxymethyl}phenyl)acetic acid | 0.24 |
NR1H3 | Oxysterols receptor LXR-alpha | 10511 | 2-[3-chloro-4-[[2-(3-chlorophenyl)-5-methyl-1,3-oxazol-4-yl]methyl-ethylamino]phenyl]-1,1,1,3,3,3-hexafluoropropan-2-ol (anilinohexafluoroisopropanol 18) | 0.3 |
NR1H3 | Oxysterols receptor LXR-alpha | 10523 | methyl 2-[N-ethyl-4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)anilino]-2-phenylbutanoate (anilinohexafluoroisopropanol 34) | 0.3 |
NR1H3 | Oxysterols receptor LXR-alpha | 7889 | 8-(dodecahydro-1H-carbazole-9-carbonyl)-4b,8-dimethyl-4b,5,6,7,8,8a,9,10-octahydrophenanthren-3-ol | 0.32 |
NR1H3 | Oxysterols receptor LXR-alpha | 10435 | 3-benzyl-4-{3-[3-(morpholine-4-carbonyl)phenoxy]phenyl}-8-(trifluoromethyl)quinoline | 0.345 |
NR1H3 | Oxysterols receptor LXR-alpha | 10479 | 5-(4-chlorophenyl)-2-(2,3-dimethoxyphenyl)-3-(2,4,6-trifluorobenzoyl)-2,3-dihydro-1,3,4-thiadiazole | 0.346 |
NR1H3 | Oxysterols receptor LXR-alpha | 7892 | N-(2,2-diphenylpropyl)-1,4a-dimethyl-1,2,3,4,4a,9,10,10a-octahydrophenanthrene-1-carboxamide | 0.36 |
NR1H3 | Oxysterols receptor LXR-alpha | 7943 | 5-[(benzenesulfonyl)({7-chloro-1H,2H,3H,4H-cyclopenta[b]indol-2-yl})fluoromethyl]-N,N-dimethyl-1,2,4-oxadiazol-3-amine | 0.37 |
NR1H3 | Oxysterols receptor LXR-alpha | 10486 | 3-[5-(4-fluorophenyl)-3-(2,4,6-trifluorobenzoyl)-2,3-dihydro-1,3,4-thiadiazol-2-yl]-2-methoxypyridine | 0.4 |
NR1H3 | Oxysterols receptor LXR-alpha | 10525 | 2-[N-ethyl-4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)anilino]-N,N-dimethyl-2-phenylpropanamide (anilinohexafluoroisopropanol 36) | 0.4 |
NR1H3 | Oxysterols receptor LXR-alpha | 10530 | 2-[3-chloro-4-[ethyl-(2-hydroxy-1-phenylethyl)amino]phenyl]-1,1,1,3,3,3-hexafluoropropan-2-ol (anilinohexafluoroisopropanol 44) | 0.4 |
NR1H3 | Oxysterols receptor LXR-alpha | 10350 | 2-ethyl-3-[3-(3-methanesulfonylphenoxy)phenyl]-8-(trifluoromethyl)imidazo[1,2-a]pyridine | 0.42 |
NR1H3 | Oxysterols receptor LXR-alpha | 7894 | 1'-(1,4a-dimethyl-1,2,3,4,4a,9,10,10a-octahydrophenanthrene-1-carbonyl)spiro[indene-1,4'-piperidine] | 0.43 |
NR1H3 | Oxysterols receptor LXR-alpha | 7940 | 2-[(benzenesulfonyl)({7-chloro-1H,2H,3H,4H-cyclopenta[b]indol-2-yl})fluoromethyl]-5-cyclopropyl-1,3,4-oxadiazole | 0.43 |
NR1H3 | Oxysterols receptor LXR-alpha | 10231 | 3-benzyl-4-{3-[3-(pyrrolidine-1-carbonyl)phenoxy]phenyl}-8-(trifluoromethyl)quinoline | 0.435 |
NR1H3 | Oxysterols receptor LXR-alpha | 10563 | 2-[4-[methyl-[3-[[7-propyl-3-(trifluoromethyl)-1,2-benzoxazol-6-yl]oxy]propyl]amino]phenyl]acetic acid | 0.45 |
NR1H3 | Oxysterols receptor LXR-alpha | 10405 | 2-[4-({[3-(3-benzyl-8-methylquinolin-4-yl)phenyl]amino}methyl)phenyl]acetic acid | 0.467 |
NR1H3 | Oxysterols receptor LXR-alpha | 10436 | 3-benzyl-4-{3-[3-(piperidine-1-carbonyl)phenoxy]phenyl}-8-(trifluoromethyl)quinoline | 0.477 |
NR1H3 | Oxysterols receptor LXR-alpha | 10573 | 2-[1-[3-[[7-propyl-3-(trifluoromethyl)-1,2-benzoxazol-6-yl]oxy]propyl]indazol-5-yl]acetic acid | 0.48 |
NR1H3 | Oxysterols receptor LXR-alpha | 10504 | 2-[3-chloro-4-[ethyl(1,3-thiazol-4-ylmethyl)amino]phenyl]-1,1,1,3,3,3-hexafluoropropan-2-ol (anilinohexafluoroisopropanol 11) | 0.5 |
NR1H3 | Oxysterols receptor LXR-alpha | 10524 | methyl 2-[2-chloro-N-ethyl-4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)anilino]-2-phenylbutanoate (anilinohexafluoroisopropanol 35) | 0.5 |
NR1H3 | Oxysterols receptor LXR-alpha | 10326 | 3-{3-[8-chloro-2-(propan-2-yl)imidazo[1,2-a]pyridin-3-yl]phenoxy}-N-methylbenzene-1-sulfonamide | 0.53 |
NR1H3 | Oxysterols receptor LXR-alpha | 10337 | 8-chloro-3-[3-(3-methanesulfonylphenoxy)phenyl]-2-(propan-2-yl)imidazo[1,2-a]pyridine | 0.54 |
NR1H3 | Oxysterols receptor LXR-alpha | 10585 | 2-[5-[methyl-[3-[[7-propyl-3-(trifluoromethyl)-1,2-benzoxazol-6-yl]oxy]propyl]amino]pyrazin-2-yl]acetic acid | 0.54 |
NR1H3 | Oxysterols receptor LXR-alpha | 10353 | 3-[3-(3-methanesulfonylphenoxy)phenyl]-2-phenyl-8-(trifluoromethyl)imidazo[1,2-a]pyridine | 0.57 |
NR1H3 | Oxysterols receptor LXR-alpha | 10571 | 2-[1-[3-[[7-propyl-3-(trifluoromethyl)-1,2-benzoxazol-6-yl]oxy]propyl]indol-5-yl]acetic acid | 0.59 |
NR1H3 | Oxysterols receptor LXR-alpha | 10478 | 5-(4-chlorophenyl)-2-(2,3-dimethoxyphenyl)-3-(2,4,6-trifluorobenzoyl)-2,3-dihydro-1,3,4-thiadiazole | 0.608 |
NR1H3 | Oxysterols receptor LXR-alpha | 10586 | 2-[2-[methyl-[3-[[7-propyl-3-(trifluoromethyl)-1,2-benzoxazol-6-yl]oxy]propyl]amino]pyrimidin-5-yl]acetic acid | 0.62 |
NR1H3 | Oxysterols receptor LXR-alpha | 10232 | 3-{3-[3-benzyl-8-(trifluoromethyl)quinolin-4-yl]phenoxy}-N,N-diethylbenzamide | 0.675 |
NR1H3 | Oxysterols receptor LXR-alpha | 10327 | 3-{3-[3-(ethanesulfonyl)phenoxy]phenyl}-2-methyl-8-(trifluoromethyl)imidazo[1,2-a]pyridine | 0.68 |
NR1H3 | Oxysterols receptor LXR-alpha | 7915 | 2-{5-[({3-[3-benzyl-8-(trifluoromethyl)quinolin-4-yl]phenyl}methyl)amino]naphthalen-1-yl}acetic acid | 0.685 |
NR1H3 | Oxysterols receptor LXR-alpha | 10333 | 2-methyl-3-{3-[3-(propane-2-sulfonyl)phenoxy]phenyl}-8-(trifluoromethyl)imidazo[1,2-a]pyridine | 0.7 |
NR1H3 | Oxysterols receptor LXR-alpha | 10493 | 2-(2,3-dimethoxyphenyl)-5-(4-fluorophenyl)-3-(2,4,5-trifluoro-3-methoxybenzoyl)-2,3-dihydro-1,3,4-thiadiazole | 0.7 |
NR1H3 | Oxysterols receptor LXR-alpha | 10505 | 2-[4-[ethyl(pyridin-2-ylmethyl)amino]phenyl]-1,1,1,3,3,3-hexafluoropropan-2-ol (anilinohexafluoroisopropanol 12) | 0.7 |
NR1H3 | Oxysterols receptor LXR-alpha | 10515 | 1,1,1,3,3,3-hexafluoro-2-[4-[[5-methyl-2-[3-(trifluoromethyl)phenyl]-1,3-oxazol-4-yl]methyl-(2,2,2-trifluoroethyl)amino]phenyl]propan-2-ol (anilinohexafluoroisopropanol 22) | 0.7 |
NR1H3 | Oxysterols receptor LXR-alpha | 10538 | methyl 4-[2-[2-chloro-N-ethyl-4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)anilino]-2-phenylethoxy]benzoate (anilinohexafluoroisopropanol 52) | 0.7 |
NR1H3 | Oxysterols receptor LXR-alpha | 10352 | 2-tert-butyl-3-[3-(3-methanesulfonylphenoxy)phenyl]-8-(trifluoromethyl)imidazo[1,2-a]pyridine | 0.71 |
NR1H3 | Oxysterols receptor LXR-alpha | 7938 | 2-[(benzenesulfonyl)({7-chloro-1H,2H,3H,4H-cyclopenta[b]indol-2-yl})fluoromethyl]-1,3,4-oxadiazole | 0.77 |
NR1H3 | Oxysterols receptor LXR-alpha | 10509 | 2-[3-chloro-4-[ethyl(2-phenylethyl)amino]phenyl]-1,1,1,3,3,3-hexafluoropropan-2-ol (anilinohexafluoroisopropanol 16) | 0.8 |
NR1H3 | Oxysterols receptor LXR-alpha | 10537 | 2-[2-[N-ethyl-4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)anilino]-2-phenylethoxy]-N,N-dimethylacetamide (anilinohexafluoroisopropanol 51) | 0.8 |
NR1H3 | Oxysterols receptor LXR-alpha | 10577 | 3-[1-[3-[[7-propyl-3-(trifluoromethyl)-1,2-benzoxazol-6-yl]oxy]propyl]indol-5-yl]propanoic acid | 0.82 |
NR1H3 | Oxysterols receptor LXR-alpha | 7930 | methyl 2-{7-chloro-1H,2H,3H,4H-cyclopenta[b]indol-2-yl}-2-(3-chlorobenzenesulfonyl)-2-fluoroacetate | 0.84 |
NR1H3 | Oxysterols receptor LXR-alpha | 10344 | 3-[3-(3-methanesulfonylphenoxy)phenyl]-2-methyl-8-(trifluoromethyl)imidazo[1,2-a]pyridine | 0.84 |
NR1H3 | Oxysterols receptor LXR-alpha | 7932 | methyl 2-(3-bromobenzenesulfonyl)-2-{7-chloro-1H,2H,3H,4H-cyclopenta[b]indol-2-yl}-2-fluoroacetate | 0.85 |
NR1H3 | Oxysterols receptor LXR-alpha | 10349 | 1-{3-[3-(3-methanesulfonylphenoxy)phenyl]-8-(trifluoromethyl)imidazo[1,2-a]pyridin-2-yl}-1H-imidazole | 0.85 |
NR1H3 | Oxysterols receptor LXR-alpha | 7941 | 5-[(benzenesulfonyl)({7-chloro-1H,2H,3H,4H-cyclopenta[b]indol-2-yl})fluoromethyl]-N,N-dimethyl-1,3,4-oxadiazol-2-amine | 0.89 |
NR1H3 | Oxysterols receptor LXR-alpha | 10325 | 3-{3-[8-chloro-2-(propan-2-yl)imidazo[1,2-a]pyridin-3-yl]phenoxy}-N-[(4-methoxyphenyl)methyl]-N-methylbenzene-1-sulfonamide | 0.89 |
NR1H3 | Oxysterols receptor LXR-alpha | 10491 | 3-(2,6-difluoro-4-methoxybenzoyl)-2-(2,3-dimethoxyphenyl)-5-(4-fluorophenyl)-2,3-dihydro-1,3,4-thiadiazole | 0.9 |
NR1H3 | Oxysterols receptor LXR-alpha | 10492 | 3-(4-bromo-2,6-difluorobenzoyl)-2-(2,3-dimethoxyphenyl)-5-(4-fluorophenyl)-2,3-dihydro-1,3,4-thiadiazole | 0.9 |
NR1H3 | Oxysterols receptor LXR-alpha | 10499 | 2-[4-[benzyl(2,2,2-trifluoroethyl)amino]phenyl]-1,1,1,3,3,3-hexafluoropropan-2-ol (anilinohexafluoroisopropanol 6) | 0.9 |
NR1H3 | Oxysterols receptor LXR-alpha | 10531 | 2-[4-[ethyl-(2-methoxy-1-phenylethyl)amino]phenyl]-1,1,1,3,3,3-hexafluoropropan-2-ol (anilinohexafluoroisopropanol 45) | 0.9 |
NR1H3 | Oxysterols receptor LXR-alpha | 10394 | 14-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)-2-methyl-2-azatricyclo[10.4.0.0?,?]hexadeca-1(16),4,6,8,12,14-hexaen-3-one | 0.91 |
NR1H3 | Oxysterols receptor LXR-alpha | 10351 | 3-[3-(3-methanesulfonylphenoxy)phenyl]-2-(propan-2-yl)-8-(trifluoromethyl)imidazo[1,2-a]pyridine | 0.95 |
NR1H3 | Oxysterols receptor LXR-alpha | 10508 | 2-[4-[ethyl(2-phenylethyl)amino]phenyl]-1,1,1,3,3,3-hexafluoropropan-2-ol (anilinohexafluoroisopropanol 15) | 1.0 |
NR1H3 | Oxysterols receptor LXR-alpha | 10512 | 2-[4-[[2-(3-chlorophenyl)-5-methyl-1,3-oxazol-4-yl]methyl-(2,2,2-trifluoroethyl)amino]phenyl]-1,1,1,3,3,3-hexafluoropropan-2-ol (anilinohexafluoroisopropanol 19) | 1.0 |
NR1H3 | Oxysterols receptor LXR-alpha | 10528 | 2-[4-[ethyl-(2-hydroxy-2-phenylethyl)amino]phenyl]-1,1,1,3,3,3-hexafluoropropan-2-ol (anilinohexafluoroisopropanol 42) | 1.0 |
NR1H3 | Oxysterols receptor LXR-alpha | 7929 | methyl 2-{7-chloro-1H,2H,3H,4H-cyclopenta[b]indol-2-yl}-2-fluoro-2-(3-methoxybenzenesulfonyl)acetate | 1.07 |
NR1H3 | Oxysterols receptor LXR-alpha | 7933 | methyl 2-{7-chloro-1H,2H,3H,4H-cyclopenta[b]indol-2-yl}-2-fluoro-2-(pyridine-3-sulfonyl)acetate | 1.07 |
NR1H3 | Oxysterols receptor LXR-alpha | 7942 | 5-[(benzenesulfonyl)({7-chloro-1H,2H,3H,4H-cyclopenta[b]indol-2-yl})fluoromethyl]-3-methyl-1,2,4-oxadiazole | 1.09 |
NR1H3 | Oxysterols receptor LXR-alpha | 10501 | 2-[4-[benzyl(ethyl)amino]phenyl]-1,1,1,3,3,3-hexafluoropropan-2-ol (anilinohexafluoroisopropanol 8) | 1.1 |
NR1H3 | Oxysterols receptor LXR-alpha | 10539 | methyl 2-[4-[2-[2-chloro-N-ethyl-4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)anilino]-2-phenylethoxy]phenyl]acetate (anilinohexafluoroisopropanol 53) | 1.1 |
NR1H3 | Oxysterols receptor LXR-alpha | 10584 | 2-[2-[methyl-[3-[[7-propyl-3-(trifluoromethyl)-1,2-benzoxazol-6-yl]oxy]propyl]amino]-1,3-thiazol-5-yl]acetic acid | 1.1 |
NR1H3 | Oxysterols receptor LXR-alpha | 10498 | tert-butyl 2-[4-(3-amino-3-oxopropyl)phenyl]indole-1-carboxylate (Boc-indole derivate 26) | 1.11 |
NR1H3 | Oxysterols receptor LXR-alpha | 10497 | 3-[4-[1-[(2-methylpropan-2-yl)oxycarbonyl]indol-2-yl]phenyl]propanoic acid (Boc-indole derivate 25) | 1.15 |
NR1H3 | Oxysterols receptor LXR-alpha | 7920 | 2-{5-[({3-[8-(trifluoromethyl)quinolin-4-yl]phenyl}methyl)amino]naphthalen-1-yl}acetic acid | 1.18 |
NR1H3 | Oxysterols receptor LXR-alpha | 10496 | tert-butyl 2-[4-(2-cyanoethyl)phenyl]indole-1-carboxylate (Boc-indole derivate 22) | 1.19 |
NR1H3 | Oxysterols receptor LXR-alpha | 10203 | 8-chloro-3-methyl-4-{3-[3-(morpholine-4-carbonyl)phenoxy]phenyl}quinoline | 1.237 |
NR1H3 | Oxysterols receptor LXR-alpha | 10580 | 2-[2-methyl-4-[methyl-[3-[[7-propyl-3-(trifluoromethyl)-1,2-benzoxazol-6-yl]oxy]propyl]amino]phenyl]acetic acid | 1.3 |
NR1H3 | Oxysterols receptor LXR-alpha | 7931 | methyl 2-{7-chloro-1H,2H,3H,4H-cyclopenta[b]indol-2-yl}-2-fluoro-2-(3-fluorobenzenesulfonyl)acetate | 1.35 |
NR1H3 | Oxysterols receptor LXR-alpha | 7939 | 2-[(benzenesulfonyl)({7-chloro-1H,2H,3H,4H-cyclopenta[b]indol-2-yl})fluoromethyl]-5-methyl-1,3,4-oxadiazole | 1.35 |
NR1H3 | Oxysterols receptor LXR-alpha | 7928 | methyl 2-(6-chloro-2,3,4,9-tetrahydro-1H-carbazol-2-yl)-2-fluoro-2-(3-fluorobenzenesulfonyl)acetate | 1.39 |
NR1H3 | Oxysterols receptor LXR-alpha | 10480 | 2-(2,3-dimethoxyphenyl)-5-(4-fluorophenyl)-3-(2,4,6-trifluorobenzoyl)-2,3-dihydro-1,3,4-thiadiazole | 1.4 |
NR1H3 | Oxysterols receptor LXR-alpha | 10481 | 2-(2,3-dimethoxyphenyl)-5-(4-methylphenyl)-3-(2,4,6-trifluorobenzoyl)-2,3-dihydro-1,3,4-thiadiazole | 1.4 |
NR1H3 | Oxysterols receptor LXR-alpha | 10540 | methyl 3-[4-[2-[2-chloro-N-ethyl-4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)anilino]-2-phenylethoxy]phenyl]propanoate (anilinohexafluoroisopropanol 54) | 1.4 |
NR1H3 | Oxysterols receptor LXR-alpha | 10339 | 3-(3-{3-[2-methyl-8-(trifluoromethyl)imidazo[1,2-a]pyridin-3-yl]phenoxy}benzenesulfonyl)propan-1-ol | 1.42 |
NR1H3 | Oxysterols receptor LXR-alpha | 10488 | 5-(3,4-difluorophenyl)-2-(2,3-dimethoxyphenyl)-3-(3-fluorobenzoyl)-2,3-dihydro-1,3,4-thiadiazole | 1.5 |
NR1H3 | Oxysterols receptor LXR-alpha | 10494 | tert-butyl 2-[2-(benzenesulfonamido)-2,3-dihydro-1H-inden-5-yl]indole-1-carboxylate (Indan derivative 1) | 1.5 |
NR1H3 | Oxysterols receptor LXR-alpha | 7936 | 2-(benzenesulfonyl)-2-{7-chloro-1H,2H,3H,4H-cyclopenta[b]indol-2-yl}-2-fluoro-N-methylacetamide | 1.55 |
NR1H3 | Oxysterols receptor LXR-alpha | 10348 | 2-ethyl-3-{3-[(3-methanesulfonylphenyl)methyl]phenyl}-8-(trifluoromethyl)imidazo[1,2-a]pyridine | 1.57 |
NR1H3 | Oxysterols receptor LXR-alpha | 10463 | (3S,8S,9S,10R,13S,14S,17S)-17-[(2R)-2-hydroxy-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol | 1.6 |
NR1H3 | Oxysterols receptor LXR-alpha | 10238 | 3-[3-(8-chloro-3-methylquinolin-4-yl)phenoxy]-N-propylbenzamide | 1.633 |
NR1H3 | Oxysterols receptor LXR-alpha | 10329 | 3-[3-(3-methanesulfonylphenoxy)phenyl]-2-(propan-2-yl)imidazo[1,2-a]pyridine-8-carbonitrile | 1.68 |
NR1H3 | Oxysterols receptor LXR-alpha | 10395 | 5-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)-9-methyl-2-methylidene-9-azatricyclo[9.4.0.0³,?]pentadeca-1(15),3,5,7,11,13-hexaen-10-one | 1.7 |
NR1H3 | Oxysterols receptor LXR-alpha | 10237 | 2-[(2,4-dimethylphenyl)methyl]-3-(4-fluorophenyl)-7-(trifluoromethyl)-2H-indazole | 1.81 |
NR1H3 | Oxysterols receptor LXR-alpha | 10484 | 2-[2-(difluoromethoxy)phenyl]-5-(4-fluorophenyl)-3-(2,4,6-trifluorobenzoyl)-2,3-dihydro-1,3,4-thiadiazole | 1.9 |
NR1H3 | Oxysterols receptor LXR-alpha | 10529 | 2-[4-[ethyl-(2-hydroxy-1-phenylethyl)amino]phenyl]-1,1,1,3,3,3-hexafluoropropan-2-ol (anilinohexafluoroisopropanol 43) | 1.9 |
NR1H3 | Oxysterols receptor LXR-alpha | 10532 | 2-[4-[ethyl-(1-phenyl-2-phenylmethoxyethyl)amino]phenyl]-1,1,1,3,3,3-hexafluoropropan-2-ol (anilinohexafluoroisopropanol 46) | 1.9 |
NR1H3 | Oxysterols receptor LXR-alpha | 10578 | 1-[3-[[7-propyl-3-(trifluoromethyl)-1,2-benzoxazol-6-yl]oxy]propyl]indole-5-carboxylic acid | 1.9 |
NR1H3 | Oxysterols receptor LXR-alpha | 10458 | (4R)-4-[(3S,10R,13R,17R)-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-N,N-dimethylpentanamide | 2.0 |
NR1H3 | Oxysterols receptor LXR-alpha | 7925 | methyl 2-(6-chloro-2,3,4,9-tetrahydro-1H-carbazol-2-yl)-2-(2-chlorobenzenesulfonyl)propanoate | 2.08 |
NR1H3 | Oxysterols receptor LXR-alpha | 10489 | 3-(3,5-difluorobenzoyl)-2-(2,3-dimethoxyphenyl)-5-(4-fluorophenyl)-2,3-dihydro-1,3,4-thiadiazole | 2.1 |
NR1H3 | Oxysterols receptor LXR-alpha | 10507 | 2-[4-[ethyl(pyridin-4-ylmethyl)amino]phenyl]-1,1,1,3,3,3-hexafluoropropan-2-ol (anilinohexafluoroisopropanol 14) | 2.1 |
NR1H3 | Oxysterols receptor LXR-alpha | 10204 | 3-[3-(8-chloro-3-methylquinolin-4-yl)phenoxy]-N-ethylbenzamide | 2.102 |
NR1H3 | Oxysterols receptor LXR-alpha | 7927 | methyl 2-(6-chloro-2,3,4,9-tetrahydro-1H-carbazol-2-yl)-2-(3-chlorobenzenesulfonyl)-2-fluoroacetate | 2.17 |
NR1H3 | Oxysterols receptor LXR-alpha | 7924 | methyl 2-(6-chloro-2,3,4,9-tetrahydro-1H-carbazol-2-yl)-2-(3-chlorobenzenesulfonyl)propanoate | 2.18 |
NR1H3 | Oxysterols receptor LXR-alpha | 10520 | 2-[N-ethyl-4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)anilino]-2-phenyl-1-piperidin-1-ylethanone (anilinohexafluoroisopropanol 31) | 2.2 |
NR1H3 | Oxysterols receptor LXR-alpha | 10533 | methyl 2-[2-[N-ethyl-4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)anilino]-2-phenylethoxy]acetate (anilinohexafluoroisopropanol 47) | 2.2 |
NR1H3 | Oxysterols receptor LXR-alpha | 7926 | methyl 2-(6-chloro-2,3,4,9-tetrahydro-1H-carbazol-2-yl)-2-(2-methoxybenzenesulfonyl)propanoate | 2.3 |
NR1H3 | Oxysterols receptor LXR-alpha | 10516 | methyl 2-[N-ethyl-4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)anilino]-2-phenylacetate (anilinohexafluoroisopropanol 27) | 2.3 |
NR1H3 | Oxysterols receptor LXR-alpha | 10574 | 2-[1-[3-[[7-propyl-3-(trifluoromethyl)-1,2-benzoxazol-6-yl]oxy]propyl]benzotriazol-5-yl]acetic acid | 2.3 |
NR1H3 | Oxysterols receptor LXR-alpha | 10490 | 2-(2,3-dimethoxyphenyl)-3-(5-fluoro-2-methylbenzoyl)-5-(4-fluorophenyl)-2,3-dihydro-1,3,4-thiadiazole | 2.4 |
NR1H3 | Oxysterols receptor LXR-alpha | 10568 | 2-[3-[methyl-[3-[[7-propyl-3-(trifluoromethyl)-1,2-benzoxazol-6-yl]oxy]propyl]amino]phenyl]acetic acid | 2.6 |
NR1H3 | Oxysterols receptor LXR-alpha | 10209 | 3-{3-[3-benzyl-8-(trifluoromethyl)quinolin-4-yl]phenoxy}-N-propylbenzamide | 2.709 |
NR1H3 | Oxysterols receptor LXR-alpha | 7934 | methyl 2-{7-chloro-1H,2H,3H,4H-cyclopenta[b]indol-2-yl}-2-fluoro-2-(pyridine-2-sulfonyl)acetate | 2.75 |
NR1H3 | Oxysterols receptor LXR-alpha | 10222 | 4-({butyl[4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)phenyl]amino}methyl)-2,6-dichlorophenol | 3.0 |
NR1H3 | Oxysterols receptor LXR-alpha | 10576 | 2-oxo-1-[3-[[7-propyl-3-(trifluoromethyl)-1,2-benzoxazol-6-yl]oxy]propyl]-3H-indole-5-carboxylic acid | 3.0 |
NR1H3 | Oxysterols receptor LXR-alpha | 7899 | N-{bicyclo[2.2.1]heptan-2-yl}-1,4a-dimethyl-1,2,3,4,4a,9,10,10a-octahydrophenanthrene-1-carboxamide | 3.1 |
NR1H3 | Oxysterols receptor LXR-alpha | 10335 | 3-{3-[(3-methanesulfonylphenyl)methoxy]phenyl}-2-(propan-2-yl)-8-(trifluoromethyl)imidazo[1,2-a]pyridine | 3.24 |
NR1H3 | Oxysterols receptor LXR-alpha | 10503 | 2-[4-[ethyl(1,3-thiazol-4-ylmethyl)amino]phenyl]-1,1,1,3,3,3-hexafluoropropan-2-ol (anilinohexafluoroisopropanol 10) | 3.3 |
NR1H3 | Oxysterols receptor LXR-alpha | 10460 | (3S,5R,10S,13R,17R)-4,4,10,13-tetramethyl-17-[(2R)-6-methylhept-5-en-2-yl]-1,2,3,5,6,7,11,12,16,17-decahydrocyclopenta[a]phenanthren-3-ol | 3.5 |
NR1H3 | Oxysterols receptor LXR-alpha | 10462 | (3S,7R,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,7-diol | 3.5 |
NR1H3 | Oxysterols receptor LXR-alpha | 10582 | 2-[4-[methyl-[3-[[7-propyl-3-(trifluoromethyl)-1,2-benzoxazol-6-yl]oxy]propyl]amino]-2-(trifluoromethyl)phenyl]acetic acid | 3.6 |
NR1H3 | Oxysterols receptor LXR-alpha | 10541 | 4-[2-[2-chloro-N-ethyl-4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)anilino]-2-phenylethoxy]benzoic acid (anilinohexafluoroisopropanol 55) | 3.7 |
NR1H3 | Oxysterols receptor LXR-alpha | 10485 | 5-(4-chlorophenyl)-2-(2,2-difluoro-2H-1,3-benzodioxol-4-yl)-3-(2,4,6-trifluorobenzoyl)-2,3-dihydro-1,3,4-thiadiazole | 3.9 |
NR1H3 | Oxysterols receptor LXR-alpha | 10393 | 5-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)-9-methyl-2-oxa-9-azatricyclo[9.4.0.0³,?]pentadeca-1(15),3,5,7,11,13-hexaen-10-one | 4.2 |
NR1H3 | Oxysterols receptor LXR-alpha | 7935 | methyl 2-(benzenesulfonyl)-2-{7-chloro-1H,2H,3H,4H-cyclopenta[b]indol-2-yl}-2-fluoroacetate | 4.23 |
NR1H3 | Oxysterols receptor LXR-alpha | 10206 | 2-benzyl-3-phenyl-7-(trifluoromethyl)-2H-indazole | 4.27 |
NR1H3 | Oxysterols receptor LXR-alpha | 10506 | 2-[4-[ethyl(pyridin-3-ylmethyl)amino]phenyl]-1,1,1,3,3,3-hexafluoropropan-2-ol (anilinohexafluoroisopropanol 13) | 4.3 |
NR1H3 | Oxysterols receptor LXR-alpha | 10543 | 3-[4-[2-[2-chloro-N-ethyl-4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)anilino]-2-phenylethoxy]phenyl]propanoic acid (anilinohexafluoroisopropanol 57) | 4.5 |
NR1H3 | Oxysterols receptor LXR-alpha | 10448 | (3S,8S,9S,10R,13S,14S,17R)-17-[(2S,3R)-3-hydroxy-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol | 5.0 |
NR1H3 | Oxysterols receptor LXR-alpha | 10583 | 2-[6-[methyl-[3-[[7-propyl-3-(trifluoromethyl)-1,2-benzoxazol-6-yl]oxy]propyl]amino]pyridin-3-yl]acetic acid | 5.0 |
NR1H3 | Oxysterols receptor LXR-alpha | 10233 | 2-[(2-chlorophenyl)methyl]-3-(4-fluorophenyl)-7-(trifluoromethyl)-2H-indazole | 5.02 |
NR1H3 | Oxysterols receptor LXR-alpha | 10542 | 2-[4-[2-[2-chloro-N-ethyl-4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)anilino]-2-phenylethoxy]phenyl]acetic acid (anilinohexafluoroisopropanol 56) | 5.5 |
NR1H3 | Oxysterols receptor LXR-alpha | 7923 | methyl 2-(6-chloro-2,3,4,9-tetrahydro-1H-carbazol-2-yl)-2-(3,4-dichlorobenzenesulfonyl)propanoate | 5.8 |
NR1H3 | Oxysterols receptor LXR-alpha | 7922 | methyl 2-(6-chloro-2,3,4,9-tetrahydro-1H-carbazol-2-yl)-2-(4-fluorobenzenesulfonyl)propanoate | 5.81 |
NR1H3 | Oxysterols receptor LXR-alpha | 10558 | 2-[3-chloro-4-[3-[[7-propyl-3-(trifluoromethyl)-1,2-benzoxazol-6-yl]oxy]propylsulfanyl]phenyl]acetic acid | 5.9 |
NR1H3 | Oxysterols receptor LXR-alpha | 10252 | 3-(3-benzyl-8-chlorocinnolin-4-yl)-N-[(1-methyl-1H-indol-2-yl)methyl]aniline | 6.0 |
NR1H3 | Oxysterols receptor LXR-alpha | 10570 | N-methyl-N-[3-[[7-propyl-3-(trifluoromethyl)-1,2-benzoxazol-6-yl]oxy]propyl]aniline | 6.0 |
NR1H3 | Oxysterols receptor LXR-alpha | 10438 | 3-(4-fluorophenyl)-2-[(2-fluorophenyl)methyl]-7-(trifluoromethyl)-2H-indazole | 6.1 |
NR1H3 | Oxysterols receptor LXR-alpha | 10487 | 5-(4-chlorophenyl)-3-(2,4-difluorobenzoyl)-2-(2,3-dimethoxyphenyl)-2,3-dihydro-1,3,4-thiadiazole | 6.7 |
NR1H3 | Oxysterols receptor LXR-alpha | 10447 | (3S,8S,9S,10R,13R,14S,17R)-17-[(2R,5R)-5-hydroxy-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol | 7.0 |
NR1H3 | Oxysterols receptor LXR-alpha | 10456 | (1S,2R,5S,7R,9S,11S,12S,15R,16R)-15-[(2R)-4-[(2S)-3,3-dimethyloxiran-2-yl]butan-2-yl]-2,16-dimethyl-8-oxapentacyclo[9.7.0.0^{2,7}.0^{7,9}.0^{12,16}]octadecan-5-ol | 7.0 |
NR1H3 | Oxysterols receptor LXR-alpha | 7919 | 2-{5-[({3-[3-methyl-8-(trifluoromethyl)quinolin-4-yl]phenyl}methyl)amino]naphthalen-1-yl}acetic acid | 7.86 |
NR1H3 | Oxysterols receptor LXR-alpha | 10452 | (3S,7S,8S,9S,10R,13R,14S,17R)-17-[(2R)-4-[(2S)-3,3-dimethyloxiran-2-yl]butan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,7-diol | 8.0 |
NR1H3 | Oxysterols receptor LXR-alpha | 10457 | methyl 4-(3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoate | 8.0 |
NR1H3 | Oxysterols receptor LXR-alpha | 10564 | 2-[4-[3-[[7-propyl-3-(trifluoromethyl)-1,2-benzoxazol-6-yl]oxy]propylamino]phenyl]acetic acid | 8.0 |
NR1H3 | Oxysterols receptor LXR-alpha | 10261 | 3-benzyl-4-{3-[(1-methyl-1H-indol-7-yl)methoxy]phenyl}-8-(trifluoromethyl)cinnoline | 8.32 |
NR1H3 | Oxysterols receptor LXR-alpha | 10235 | 3-(4-fluorophenyl)-2-[(4-fluorophenyl)methyl]-7-(trifluoromethyl)-2H-indazole | 8.4 |
NR1H3 | Oxysterols receptor LXR-alpha | 10251 | 3-benzyl-4-(3-{[5-fluoro-2-(trifluoromethyl)phenyl]methoxy}phenyl)-8-(trifluoromethyl)cinnoline | 8.41 |
NR1H3 | Oxysterols receptor LXR-alpha | 10521 | 2-[N-ethyl-4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)anilino]-1-morpholin-4-yl-2-phenylethanone (anilinohexafluoroisopropanol 32) | 8.5 |
NR1H3 | Oxysterols receptor LXR-alpha | 10519 | 2-[N-ethyl-4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)anilino]-N,N-dimethyl-2-phenylacetamide (anilinohexafluoroisopropanol 30) | 9.3 |
NR1H3 | Oxysterols receptor LXR-alpha | 10517 | 2-[N-ethyl-4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)anilino]-2-phenylacetic acid (anilinohexafluoroisopropanol 28) | 9.4 |
NR1H3 | Oxysterols receptor LXR-alpha | 10443 | (1S,2R,5S,10S,11S,14R,15R)-14-[(2R)-4-[(2R)-3,3-dimethyloxiran-2-yl]butan-2-yl]-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-5-ol | 10.0 |
NR1H3 | Oxysterols receptor LXR-alpha | 10535 | 2-[2-[N-ethyl-4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)anilino]-2-phenylethoxy]acetic acid (anilinohexafluoroisopropanol 49) | 10.0 |
NR1H3 | Oxysterols receptor LXR-alpha | 10518 | 2-[N-ethyl-4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)anilino]-N-methyl-2-phenylacetamide (anilinohexafluoroisopropanol 29) | 10.9 |
NR1H3 | Oxysterols receptor LXR-alpha | 10249 | 3-(3-benzyl-8-chlorocinnolin-4-yl)-N-{[2-chloro-3-(trifluoromethyl)phenyl]methyl}aniline | 11.1 |
NR1H3 | Oxysterols receptor LXR-alpha | 10266 | 3-[3-benzyl-8-(trifluoromethyl)quinolin-4-yl]-N-[(1-methyl-1H-indol-7-yl)methyl]aniline | 12.0 |
NR1H3 | Oxysterols receptor LXR-alpha | 10439 | 2-[(4-chlorophenyl)methyl]-3-(4-fluorophenyl)-7-(trifluoromethyl)-2H-indazole | 12.77 |
NR1H3 | Oxysterols receptor LXR-alpha | 10211 | 2-[(4-chloro-2-fluorophenyl)methyl]-3-(4-chlorophenyl)-7-(trifluoromethyl)-2H-indazole | 13.28 |
NR1H3 | Oxysterols receptor LXR-alpha | 10239 | 3-(4-chlorophenyl)-2-[(2-fluorophenyl)methyl]-7-(trifluoromethyl)-2H-indazole | 13.44 |
NR1H3 | Oxysterols receptor LXR-alpha | 10257 | 3-[3-benzyl-8-(trifluoromethyl)quinolin-4-yl]-N-[(1-methyl-1H-indol-2-yl)methyl]aniline | 13.5 |
NR1H3 | Oxysterols receptor LXR-alpha | 10240 | 2-[(2-chloro-4-fluorophenyl)methyl]-3-(4-chlorophenyl)-7-(trifluoromethyl)-2H-indazole | 14.4 |
NR1H3 | Oxysterols receptor LXR-alpha | 10213 | 3-(4-chlorophenyl)-2-[(2-chlorophenyl)methyl]-7-(trifluoromethyl)-2H-indazole | 15.21 |
NR1H3 | Oxysterols receptor LXR-alpha | 10253 | 3-benzyl-8-chloro-4-(3-{[2-chloro-3-(trifluoromethyl)phenyl]methoxy}phenyl)cinnoline | 15.3 |
NR1H3 | Oxysterols receptor LXR-alpha | 10210 | 3-(4-chlorophenyl)-7-(trifluoromethyl)-2-{[2-(trifluoromethyl)phenyl]methyl}-2H-indazole | 15.83 |
NR1H3 | Oxysterols receptor LXR-alpha | 10269 | 3-benzyl-4-(3-{[2-chloro-3-(trifluoromethyl)phenyl]methoxy}phenyl)-8-(trifluoromethyl)cinnoline | 18.1 |
NR1H3 | Oxysterols receptor LXR-alpha | 10534 | 2-[4-[ethyl-[2-(2-hydroxyethoxy)-1-phenylethyl]amino]phenyl]-1,1,1,3,3,3-hexafluoropropan-2-ol (anilinohexafluoroisopropanol 48) | 40.0 |
NR1H3 | Oxysterols receptor LXR-alpha | 10536 | 2-[2-[N-ethyl-4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)anilino]-2-phenylethoxy]-N-methylacetamide (anilinohexafluoroisopropanol 50) | 40.0 |
NR1H3 | Oxysterols receptor LXR-alpha | 7898 | 1-(1,4a-dimethyl-1,2,3,4,4a,9,10,10a-octahydrophenanthren-1-yl)-3-(adamantan-1-yl)propane-1,3-dione | 50.0 |
NR1H3 | Oxysterols receptor LXR-alpha | 10588 | (1S,4aS,10aR)-6-hydroxy-1,4a-dimethyl-2,3,4,9,10,10a-hexahydrophenanthrene-1-carboxylic acid | 50.0 |